ArticleHealth services research2013
Responses to Medicare drug costs among near-poor versus subsidized beneficiaries.
Article in Health services research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- State Expansions in Medicaid Financial Assistance for Low-Income Medicare Beneficiaries: Changes in Enrollment and Use.Health services research · 2026Article
- Health Care Affordability Problems by Income Level and Subsidy Eligibility in Medicare.JAMA network open · 2025Article
- Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries.The New England journal of medicine · 2025Article
- Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis.JAMA health forum · 2025Article
- Associations Between Annual Medicare Part D Low-Income Subsidy Loss and Prescription Drug Spending and Use.JAMA health forum · 2024Article
- Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey.Journal of general internal medicine · 2020Article
- Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk.PloS one · 2018Article
- Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare Beneficiaries.PloS one · 2015Article
- Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.Pharmacotherapy · 2014Article
- Community characteristics and mortality: the relative strength of association of different community characteristics.American journal of public health · 2014Article
- Financial barriers to care among low-income children with asthma: health care reform implications.JAMA pediatrics · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThere is limited information on the protective value of Medicare Part D low-income subsidies (LIS). We compared responses to drug costs for LIS recipients with near-poor (≤200 percent of the Federal Poverty Level) and higher income beneficiaries without the LIS. DATA SOURCES/STUDY
settingMedicare Advantage beneficiaries in 2008. STUDY
designWe examined three drug cost responses using multivariate logistic regression: cost-reducing behaviors (e.g., switching to generics), nonadherence (e.g., not refilling prescriptions), and financial stress (e.g., going without necessities). DATA COLLECTION: Telephone interviews in a stratified random sample (N = 1,201, 70 percent response rate). PRINCIPAL
findingsAfter adjustment, a comparable percentage of unsubsidized near-poor (26 percent) and higher income beneficiaries reported cost-reducing behaviors (23 percent, p = .63); fewer LIS beneficiaries reported cost-reducing behaviors (15 percent, p = .019 vs near-poor). Unsubsidized near-poor beneficiaries were more likely to reduce adherence (8.2 percent) than higher income (3.5 percent, p = .049) and LIS beneficiaries (3.1 percent, p = .027). Near-poor beneficiaries also more frequently experienced financial stress due to drug costs (20 percent) than higher income beneficiaries (11 percent, p = .050) and LIS beneficiaries (11 percent, p = .015).
conclusionsLow-income subsidies provide protection from drug cost-related nonadherence and financial stress. Beneficiaries just above the LIS income threshold are most at risk for these potentially adverse behaviors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.